FAQs
Can I use 40+ Period Support capsules if I’m not menopausal just yet?
Yes. Our formulas are made up of all-natural ingredients and can be used for daily support whether you are in perimenopause or not.
Can I use 40+ Period Support with other medications?
Wile formulas are designed to be used together as needed. Please speak to your doctor or health care professional before taking 40+ Period Support capsules with other medications.
What is the shelf life?
24 months.
When should I expect effects?
While everyone is unique, expect some benefits within the first 30 days with improvements building at 60 to 90 days. Within 3 months, your body will be getting the full benefits, maintained with ongoing daily use. This is typical of natural supplement which have a progressive, cumulative way of working with the body.
Are there clinical studies supporting 40+ Period Support?
Studies on ingredients include:
Ooi SL et al. J Vitex Agnus-Castus for the Treatment of Cyclic Mastalgia: A Systematic Review and Meta-AnalysisWomens Health (Larchmt) 2020;29(2):262-78 (PMID: 31464546)
Csupor D et al. Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomized controlled trials. Complement Ther Med 2019;47:102190 (PMID: 31780016)
Berger D et al. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS) Arch Gynecol Obstet 2000;264(3):150-3 (PMID: 11129515)
Evaluating the effect of fennel soft capsules on the quality of life
and its different aspects in menopausal women: A randomized clinical trial. Rahimi-Kian F et al. Nurs Pract Today 2017;4(2):87-95
Effect of Fennel on the Health Status of Menopausal Women: A
Systematic and Meta-analysis
Khadivadeh T et al. J Menopausal Med 2018;24(1):67-74 (PMID:
29765930)
The effect of Glycyrrhiza glabra L. on Primary Dysmenorrhea compared with Ibuprofen. Jafari Z, Emtiazy M, Sohrabvand F, et al. The effect of glycyrrhiza glabra l. On primary dysmenorrhea compared with ibuprofen: a randomized, triple-blind controlled trial. Iran J Pharm Res.
2019;18(Suppl1):291-301.